Literature DB >> 10878185

Muscular dystrophy.

E H Roland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10878185     DOI： 10.1542/pir.21-7-233

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN： 0191-9601


× No keyword cloud information.
  8 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

Review 2.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

Review 3.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

4.  Can children with spina bifida and muscular dystrophy participate in their own health status evaluations?

Authors:  Susan C McLimont; Janice L Owen; James G Wright
Journal:  J Child Orthop       Date:  2010-03-11       Impact factor: 1.548

5.  Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.

Authors:  Suriyan Ponnusamy; Ryan D Sullivan; Dahui You; Nadeem Zafar; Chuan He Yang; Thirumagal Thiyagarajan; Daniel L Johnson; Maron L Barrett; Nikki J Koehler; Mayra Star; Erin J Stephenson; Dave Bridges; Stephania A Cormier; Lawrence M Pfeffer; Ramesh Narayanan
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

6.  Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver.

Authors:  Michael S Hughes; Jon N Marsh; Kirk D Wallace; Tamara A Donahue; Anne M Connolly; Gregory M Lanza; Samuel A Wickline
Journal:  Ultrasound Med Biol       Date:  2007-04-30       Impact factor: 2.998

7.  Latent physiological factors of complex human diseases revealed by independent component analysis of clinarrays.

Authors:  David P Chen; Joel T Dudley; Atul J Butte
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

8.  Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.

Authors:  M Elbaz; N Yanay; S Laban; M Rabie; S Mitrani-Rosenbaum; Y Nevo
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.